Michela Serresi, PhD, is an associate research scientist in Molecular Oncology at the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and team leader, BSIO-Female Independence Awardee at the Berlin School of Integrative Oncology in Berlin, Germany.

She is a molecular biologist, experienced in applying cutting-edge genomic technologies, such as the CRISPR/Cas9 genome editing system, to cancer research. Her studies focus on metastasis, the most common and serious complication in cancer patients, and are aimed at identifying the genes that induce lung cancer cells to spread to distal organs and understanding their mechanism of action. Knowledge of these mechanisms is crucial for ‘identifying high-risk patients and developing personalised therapies’.

She is an awardee of the BSIO Female Independence Award, the prestigious prize for young female cancer researchers and, among other awards,she obtained a Research Grant from the German Research Foundation (DFG).